Can-Fite Biopharma Mutual Funds

Health Care & Life Sciences » Biotechnology | Can-Fite Biopharma Ltd.

Can-Fite Biopharma Ltd. ADR | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Dash Foreign Stocks

339,130

1.7%

50,000

0.97%

06/28/2018

Taylor North American Equity Opportunities Fund

277,900

1.39%

1.73%

06/30/2017

136,300

0.68%

1.21%

08/31/2018

View Profile

Address	Kiryat Matalon Petach Tikva TA 4951778 Israel
Employees	-
Website	http://www.canfite.com
Updated	07/08/2019
Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer.